|
|
|
|
Дата |
|---|
| 16.09.2026 |
| 15.09.2026 |
| 14.09.2026 |
| 11.09.2026 |
| 10.09.2026 |
| 09.09.2026 |
| 08.09.2026 |
| 07.09.2026 |
| 04.09.2026 |
| 03.09.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
36 700.00
|
36 000.00
|
37 000.00
|
36 500.00
|
|
|
418 290 000.00
|
|
|
|
|
36 400.00
|
36 150.00
|
37 000.00
|
37 000.00
|
|
|
113 500 000.00
|
|
|
|
|
37 100.00
|
37 000.00
|
37 100.00
|
37 000.00
|
|
|
81 610 000.00
|
|
|
|
|
36 450.00
|
36 200.00
|
37 500.00
|
37 100.00
|
|
|
169 110 000.00
|
|
|
|
|
36 900.00
|
36 500.00
|
36 900.00
|
36 500.00
|
|
|
117 050 000.00
|
|
|
|
|
37 000.00
|
36 500.00
|
37 000.00
|
36 900.00
|
|
|
84 750 000.00
|
|
|
|
|
37 000.00
|
36 600.00
|
37 000.00
|
37 000.00
|
|
|
62 340 000.00
|
|
|
|
|
37 000.00
|
36 900.00
|
37 000.00
|
36 900.00
|
|
|
33 260 000.00
|
|
|
|
|
37 000.00
|
37 000.00
|
37 000.00
|
37 000.00
|
|
|
118 400 000.00
|
|
|
|
|
35 550.00
|
35 550.00
|
37 000.00
|
37 000.00
|
|
|
147 710 000.00
|
|
Период |
|---|
| 2025, регулярные |
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2023, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
21.07.2026
|
22.07.2026 |
2000 VND |
|
31.12.2025
|
05.01.2026 |
2000 VND |
|
13.06.2025
|
16.06.2025 |
2000 VND |
|
17.06.2024
|
18.06.2024 |
2000 VND |
|
16.01.2024
|
17.01.2024 |
2000 VND |
|
19.01.2021
|
20.01.2021 |
2000 VND |
|
01.01.2020
|
02.01.2020 |
2000 VND |
|
04.01.2019
|
07.01.2019 |
2000 VND |
|
27.12.2017
|
28.12.2017 |
2000 VND |
|
03.01.2017
|
04.01.2017 |
2000 VND |
Traphaco JSC is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry.
